NCT06005766

Brief Summary

Deficiencies in social cognition are part of the core symptomatology of psychotic disorders. And deficiencies in social cognition, the closely related concept of metacognition, and, for example, paranoid attitudes are all associated with violence. The link between social cognition and violence is also observed through rehabilitation, as both group-based Social Cognition Interaction Training (SCIT) and group-based Metacognitive Skills Training (MCT) have reduced violent behavior in patients with psychotic disorders. Thus, a better knowledge of social cognition and its rehabilitation in psychotic disorders can help to reduce risky behavior and to rehabilitate the significant social difficulties often found in psychotic disorders. This research study aims to examine factors underlying the efficacy of group-based MCT. The goal of the metacognitive skills training group developed by Moritz and partners is to strengthen the social and metacognitive skills of the patients participating in the group. The group consists of 10 sessions during which exercises and discussion are emphasized. The themes of the group sessions are, for example, jumping to conclusions -bias, empathy, and memory. Detailed information is available from the MCT website (https://clinical-neuropsychology.de/metacognitive\_training-psychosis/). Overall there is meta-analysis-level evidence for the moderate effectiveness of MCT on positive symptoms of psychotic illnesses, such as delusions. Prior studies have argued that the unique factor underpinning MCT's efficacy is its impact on various cognitive biases, and that participating in the group especially reduces patients' tendency to jump to conclusions, which is a cognitive style associated with delusions and deficits in social perception and reasoning. As delusionality is related to the risk of violence, these results form a logical link between jumping to conclusions, delusionality, and violence. But the results regarding the effectiveness of MCT are still somewhat conflicting, and studies seem to be of varying quality. Additional longitudinal research and research related to the jumping to conclusion bias are also needed. The hypothesis regarding this study is that the MCT group reduces patients' tendency to jump to conclusions. These reductions are presumed to be associated in one-year follow-up with fewer mood symptoms, delusions, paranoia, and more psychological flexibility.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
85

participants targeted

Target at P50-P75 for not_applicable schizophrenia

Timeline
7mo left

Started Sep 2023

Typical duration for not_applicable schizophrenia

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress83%
Sep 2023Dec 2026

First Submitted

Initial submission to the registry

August 15, 2023

Completed
7 days until next milestone

First Posted

Study publicly available on registry

August 22, 2023

Completed
10 days until next milestone

Study Start

First participant enrolled

September 1, 2023

Completed
3.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2026

Last Updated

May 14, 2024

Status Verified

May 1, 2024

Enrollment Period

3.3 years

First QC Date

August 15, 2023

Last Update Submit

May 13, 2024

Conditions

Keywords

Social CognitionMetacognitive Skills TrainingForensic PsychologyForensic PsychiatryViolence

Outcome Measures

Primary Outcomes (1)

  • Jumping to conclusions bias

    The bias is measured using a revised version of the beads task. This is a test of optimal performance, meaning that both low and high scores can be problematic.

    For the intervention group, the measurement is done before the group and nine months after completion. For the control groups, the time interval is one year.

Secondary Outcomes (3)

  • Paranoia and psychotic experiences

    For the intervention group, the measurement is done before the group and nine months after completion. For the control groups, the time interval is one year.

  • Mood symptoms

    For the intervention group, the measurement is done before the group and nine months after completion. For the control groups, the time interval is one year.

  • Psychological flexibility

    For the intervention group, the measurement is done before the group and nine months after completion. For the control groups, the time interval is one year.

Study Arms (3)

Intervention group

EXPERIMENTAL

Patients with a psychosis spectrum disorder participating in the group-based metacognitive skills training and receiving treatment as usual

Behavioral: Metacognitive Skills Training (MCT)Other: Treatment as usual

Patient controls

ACTIVE COMPARATOR

Patients with a psychosis spectrum disorder receiving standard long-term care in the hospital

Other: Treatment as usual

Non-patient controls

NO INTERVENTION

Control group consisting of test subjects without a diagnosis of psychosis spectrum disorder

Interventions

The goal of the metacognitive skills training group developed by Moritz and co. is to strengthen the social and metacognitive skills of the patients participating in the group. The group consists of 10 sessions during which exercises and discussion are emphasized. The themes of the group sessions are, for example, jumping to conclusions -bias, empathy, and memory. Detailed information is available from the MCT website (https://clinical-neuropsychology.de/metacognitive\_training-psychosis/). Overall there is meta-analysis-level evidence for the moderate effectiveness of MCT on positive symptoms of psychotic illnesses, such as delusions. Prior studies have argued that the unique factor underpinning MCT's efficacy is its impact on various cognitive biases, and that participating in the group especially reduces patients' tendency to jump to conclusions, which is a cognitive style associated with delusions and deficits in social perception and reasoning.

Intervention group

Medicinal treatment deemed appropriate by the attending physician, psychiatric ward treatment, and others forms of treatment recommended to the patients based on their treatment plans (e.g., work therapy, dialectical behavior therapy, talk therapy)

Intervention groupPatient controls

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Willingness to participate in a scientific study
  • Diagnosis of a psychosis spectrum disorder
  • Finnish language skills due to questionnaires and psychological tests being in Finnish

You may not qualify if:

  • Psychosis that severely deteriorates the ability to function
  • Cognitive problems that severely deteriorate the ability to function
  • Guardianship established for personal matters
  • Willingness to participate in a scientific study
  • Self-assessed sufficient Finnish language skills due to questionnaires and psychological tests being in Finnish
  • Diagnosis of a psychosis spectrum disorder
  • Cognitive problems that severely interferes with functioning

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Vanha Vaasa Hospital

Vaasa, Finland

RECRUITING

MeSH Terms

Conditions

SchizophreniaPsychotic DisordersSchizophrenia, Paranoid

Interventions

Therapeutics

Condition Hierarchy (Ancestors)

Schizophrenia Spectrum and Other Psychotic DisordersMental Disorders

Study Officials

  • Raimo Lappalainen, PhD

    University of Jyvaskyla

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Leo Kuutti, MA

CONTACT

Alice Keski-Valkama, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: There are three groups in the study. One is the intervention group (n=20-25), one consists of patient controls (n=30), and the last one consists of non-patient controls (n=30).
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 15, 2023

First Posted

August 22, 2023

Study Start

September 1, 2023

Primary Completion (Estimated)

December 1, 2026

Study Completion (Estimated)

December 1, 2026

Last Updated

May 14, 2024

Record last verified: 2024-05

Data Sharing

IPD Sharing
Will share

Ownership of the data will reside with the University of Jyväskylä and Vanha Vaasa Hospital. The data are managed by the Ph.D. student, the PI, and the rest of the research team. Other researchers can use the data; however, it requires a research plan and the permission of the research team. Principally, the Ph.D. student, the PI, or someone from the research team will be one of the co-authors in all publications written from the data.

Locations